Neuroendocrine Cancer

>

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

Latest News

Image of pancreas.
FDA Approves Cabometyx, Another Treatment for Neuroendocrine Tumors

April 14th 2025

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Word cloud with the words "clinical trial" prominent
Trial of SVV-001, Opdivo and Yervoy in Neuroendocrine Tumors Launching

April 14th 2025

"FDA" text.
FDA Approves Cabometyx for Some Neuroendocrine Tumors

March 26th 2025

Illustration of cells.
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset

March 7th 2025

Image of GI cancer.
ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs

February 2nd 2025

Video Interviews
Podcasts
Cancer Survivor Tara Rolle holding a copy of her book, "The White Noise of Survivorship and Other Unsolicited Lessons I Learned From Cancer"

More News